Abingdon, United Kingdom

Elaine Harper


 

 

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Elaine Harper in Therapeutic Fusion Proteins

Introduction

Elaine Harper, a pioneering inventor based in Abingdon, GB, has made significant contributions to the field of biomedicine with her innovative work in therapeutic fusion proteins. With a total of three patents to her name, Harper is at the forefront of developing advanced solutions for targeted secretion inhibition.

Latest Patents

Among her latest patents, one stands out as a groundbreaking invention. Harper's patent focuses on a new class of Targeted Secretion Inhibitors (TSIs) that involve the construction of a single-chain fusion protein precursor. This innovative approach incorporates a non-cytotoxic protease, translocation peptide, and targeting moiety peptide. Notably, the targeting moiety peptide is designed with a free N-terminal domain and a free C-terminal domain, enhancing its efficacy in medical applications. The method of activating this single-chain fusion protein precursor marks a significant advancement in therapeutic protein engineering.

Career Highlights

Harper's career includes valuable stints with Ipsen Bioinnovation Limited, where she applied her expertise to push the boundaries of biopharmaceutical innovations. Her insights and persistent efforts have positioned her as a key player in her field, contributing to advancements that promise better therapeutic outcomes.

Collaborations

Throughout her career, Elaine has collaborated with notable professionals, including her coworker John Andrew Chaddock. These collaborations have enhanced her capacity for innovation, resulting in significant contributions to therapeutic research and development.

Conclusion

Elaine Harper exemplifies the spirit of innovation with her impressive portfolio of patents and collaborative efforts. Her work on therapeutic fusion proteins highlights her commitment to advancing biomedicine and illustrates her potential for driving future innovations in the industry. As the landscape of medicinal biotechnology continues to evolve, Elaine Harper's contributions will undoubtedly play a critical role in shaping its future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…